PeptideDB

GW-870086 827319-43-7

GW-870086 827319-43-7

CAS No.: 827319-43-7

GW-870086 is a novel and potent glucocorticoid receptor agonist that has anti-inflammatory properties, and thus can be p
Sales Email:peptidedb@qq.com

This product is for research use only, not for human use. We do not sell to patients.

GW-870086 is a novel and potent glucocorticoid receptor agonist that has anti-inflammatory properties, and thus can be potentially usef for the treatment of asthma and atopic dermatitis.. It acts as a glucocorticoid receptor agonist with a pIC50 of 10.1 in A549 cells expressing NF-κB.



Physicochemical Properties


Molecular Formula C31H39F2NO6
Molecular Weight 559.641276597977
Exact Mass 559.275
Elemental Analysis C, 66.53; H, 7.02; F, 6.79; N, 2.50; O, 17.15
CAS # 827319-43-7
PubChem CID 11376392
Appearance White to off-white solid powder
LogP 4.582
Hydrogen Bond Donor Count 1
Hydrogen Bond Acceptor Count 9
Rotatable Bond Count 6
Heavy Atom Count 40
Complexity 1280
Defined Atom Stereocenter Count 9
SMILES

O([C@@]1([C@H](C)C[C@H]2[C@@H]3C[C@H](F)C4=CC(C=C[C@]4(C)[C@]3([C@H](C[C@]12C)O)F)=O)C(=O)OCC#N)C(C1C(C)(C)C1(C)C)=O

InChi Key WUBKGTSFJSEIEM-NSHBDUGJSA-N
InChi Code

InChI=1S/C31H39F2NO6/c1-16-12-18-19-14-21(32)20-13-17(35)8-9-28(20,6)30(19,33)22(36)15-29(18,7)31(16,25(38)39-11-10-34)40-24(37)23-26(2,3)27(23,4)5/h8-9,13,16,18-19,21-23,36H,11-12,14-15H2,1-7H3/t16-,18+,19+,21+,22+,28+,29+,30+,31+/m1/s1
Chemical Name

Androsta-1,4-diene-17-carboxylic acid, 6,9-difluoro-11-hydroxy-16-methyl-3-oxo-17-(((2,2,3,3-tetramethylcyclopropyl)carbonyl)oxy)-, cyanomethyl ester, (6alpha,11beta,16alpha,17alpha)-
Synonyms

GW-870086; GW-870086X; 870086; GW870086; GW870086X; GW 870086; GW 870086X
HS Tariff Code 2934.99.9001
Storage

Powder-20°C 3 years

4°C 2 years

In solvent -80°C 6 months

-20°C 1 month

Shipping Condition Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs)

Biological Activity


ln Vitro The glucocorticoid receptor agonist GW-870086 has a pIC50 of 10.1 and suppresses the NFkB reporter gene; however, it has no effect on the MMTV reporter gene in A549 cells, nor on the progesterone or estrogen receptors. little or nonexistent action at androgen or mineralocorticoid receptors. GW-870086 (1 pM-1 μM) suppresses IL-1-induced L-6 release in MG63 osteosarcoma cells and dose-dependently TNF-α in A549 epithelial cancer cells (pIC50s, 9.6, 10.2)[1]. GW-870086 (GW870086X; 10-100 nM) dramatically boosts the release of fibronectin. GW-870086, however, does not enhance cellular myofibrillar protein or affect MMP2 secretion [2].
References

[1]. Discovery of GW870086: a potent anti-inflammatory steroid with a unique pharmacological profile. Br J Pharmacol. 2013 Jul;169(6):1389-403.

[2]. Unique response profile of trabecular meshwork cells to the novel selective glucocorticoid receptor agonist, GW870086X. Invest Ophthalmol Vis Sci. 2013 Mar 1;54(3):2100-7.

Additional Infomation GW870086X has been investigated for the treatment of ASTHMA.

Solubility Data


Solubility (In Vitro) DMSO : ~100 mg/mL (~178.69 mM)
Solubility (In Vivo) Solubility in Formulation 1: ≥ 2.5 mg/mL (4.47 mM) (saturation unknown) in 10% DMSO + 40% PEG300 + 5% Tween80 + 45% Saline (add these co-solvents sequentially from left to right, and one by one), clear solution.
For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 25.0 mg/mL clear DMSO stock solution to 400 μL PEG300 and mix evenly; then add 50 μL Tween-80 to the above solution and mix evenly; then add 450 μL normal saline to adjust the volume to 1 mL.
Preparation of saline: Dissolve 0.9 g of sodium chloride in 100 mL ddH₂ O to obtain a clear solution.

Solubility in Formulation 2: ≥ 2.5 mg/mL (4.47 mM) (saturation unknown) in 10% DMSO + 90% Corn Oil (add these co-solvents sequentially from left to right, and one by one), clear solution.
For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 25.0 mg/mL clear DMSO stock solution to 900 μL of corn oil and mix evenly.

 (Please use freshly prepared in vivo formulations for optimal results.)
Preparing Stock Solutions 1 mg 5 mg 10 mg
1 mM 1.7869 mL 8.9343 mL 17.8686 mL
5 mM 0.3574 mL 1.7869 mL 3.5737 mL
10 mM 0.1787 mL 0.8934 mL 1.7869 mL
*Note: Please select an appropriate solvent for the preparation of stock solution based on your experiment needs. For most products, DMSO can be used for preparing stock solutions (e.g. 5 mM, 10 mM, or 20 mM concentration); some products with high aqueous solubility may be dissolved in water directly. Solubility information is available at the above Solubility Data section. Once the stock solution is prepared, aliquot it to routine usage volumes and store at -20°C or -80°C. Avoid repeated freeze and thaw cycles.